XML 198 R13.htm IDEA: XBRL DOCUMENT v3.25.0.1
Revenues and Deferred Costs
 12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenues and Deferred Costs Revenues and Deferred Costs
The following table disaggregates the Company's revenue by major source for the years ended December 31, 2024, 2023, and 2022:

Year ended December 31,
(in thousands)202420232022
SaaS subscription services$319,243 $252,348 $194,387 
Implementation services7,604 8,488 6,941 
Other services7,002 3,995 2,942 
Total revenues$333,849 $264,831 $204,270 

The Company recognized approximately $8.6 million of revenue during the year ended December 31, 2024 that was included in deferred revenue in the accompanying consolidated balance sheets as of the beginning of the reporting period. For those contracts that were wholly or partially unsatisfied as of December 31, 2024, the Company’s remaining performance obligation totaled approximately $1.4 billion. The Company expects to recognize approximately 47.3% of these remaining performance obligations as revenue over the next 24 months, an additional 35.1% in the next 25 to 48 months, and the remaining balance thereafter. This estimate does not include estimated consideration for excess user and transaction processing fees that the Company expects to earn under its subscription contracts.

Contract assets totaled $1.9 million and $1.5 million as of December 31, 2024 and 2023, respectively, which are included in other assets in the accompanying consolidated balance sheets.

Deferred Cost Recognition

The Company capitalized $9.9 million, $8.7 million, and $8.3 million in deferred commissions costs during the years ended December 31, 2024, 2023, and 2022, respectively, and recognized amortization of $5.1 million, $3.8 million, and $2.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of operations. Deferred commissions are considered costs to obtain a contract and are included in deferred costs in the accompanying consolidated balance sheets in the amount of $25.9 million and $21.2 million as of December 31, 2024 and 2023, respectively.

The Company capitalized implementation costs of $10.2 million, $8.4 million, and $6.9 million during the years ended December 31, 2024, 2023, and 2022, respectively, and recognized amortization of $5.6 million, $4.9 million, and $3.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. Amortization expense is included in cost of revenues in the accompanying consolidated statements of operations. These deferred costs are considered costs to fulfill client contracts and are included in deferred costs in the accompanying consolidated balance sheets in the amount of $24.5 million and $19.8 million as of December 31, 2024 and 2023, respectively.

The Company periodically reviews the carrying amount of deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. No impairment loss was recognized in relation to these capitalized costs for the years ended December 31, 2024, 2023, and 2022.